Arora T

No ORCID on file · 4 papers in corpus · active 2021-2026
2026
Frontiers in reproductive health ·doi:10.3389/frph.2026.1753608

BackgroundPolycystic Ovary Syndrome (PCOS), a prevalent metabolic and reproductive disorder, significantly impacts women of reproductive age. The conventional approach offers various symptomatic pharmacological interventions for PCOS, but s…

2025
Pharmaceuticals (Basel, Switzerland) ·doi:10.3390/ph18050680

Background: Polycystic ovary syndrome (PCOS) is an endocrine disorder prevalent in women of reproductive age. Treatment or management of this syndrome includes several pharmacological and non-pharmacological treatment approaches for differe…

2023
Trials ·doi:10.1186/s13063-023-07466-y

BackgroundPolycystic ovary syndrome (PCOS) is a common endocrine condition which affects women in the reproductive age group. South Asian women with PCOS have a higher risk of insulin resistance and metabolic disorder compared to women from…

2021
BMC public health ·doi:10.1186/s12889-021-11603-0

BackgroundInteroception is mental awareness, recognition and acknowledgement of physiological body signals. Understanding the role of sleep and interoception may provide a better understanding surrounding the sleep-health connection. Our pr…